Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Trans R Soc Trop Med Hyg ; 106(5): 283-8, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22348817

RESUMO

This study aims at estimating the prevalence of Leishmania infection among HIV-infected patients through the use of non-invasive tests. The study was conducted in three Infectious Diseases Services in two large Brazilian cities, both endemic areas for visceral leishmaniasis. Three hundred and eighty-one asymptomatic patients were enrolled whose ages ranged from 19 to 58 years old; 63.5% were men; mean TCD4+ was 380 cells/µl; and mean viral load was 153800 copies/ml. All individuals were tested for Leishmania infection through: ELISA using crude Leishmania infantum (ELISA), ELISA using the recombinant K39 antigen (rK39), indirect fluorescent antibody test (IFAT) and PCR targeted to kDNA region. The tests' positivity were: 10.8% (ELISA), 3.9% (IFAT), 0.8% (rK39), 6.3% PCR and 20.2% (overall, at least one positive test), with no statistical correlation between positivity and clinical and laboratorial variables. Concordance among tests was low (Kappa <0.20). Prevalence of Leishmania asymptomatic infection was high in this population, reinforcing the need for attention in the evaluation of HIV patients from endemic areas. New efforts are needed to develop more specific and sensitive tests to diagnose Leishmania asymptomatic infection. Highly active antiretroviral therapy (HAART) seems to have a protective role against disease progression in co-infected individuals.


Assuntos
Infecções Oportunistas Relacionadas com a AIDS/epidemiologia , Soropositividade para HIV/epidemiologia , HIV-1/imunologia , Leishmania/isolamento & purificação , Leishmaniose Visceral/epidemiologia , Infecções Oportunistas Relacionadas com a AIDS/imunologia , Infecções Oportunistas Relacionadas com a AIDS/parasitologia , Adulto , Brasil/epidemiologia , Linfócitos T CD4-Positivos , Estudos Transversais , DNA de Cinetoplasto/isolamento & purificação , Ensaio de Imunoadsorção Enzimática , Feminino , Citometria de Fluxo , Soropositividade para HIV/complicações , Soropositividade para HIV/imunologia , Humanos , Leishmania/genética , Leishmaniose Visceral/imunologia , Leishmaniose Visceral/parasitologia , Masculino , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase , Prevalência , Adulto Jovem
2.
Trans R Soc Trop Med Hyg ; 102(6): 548-55, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18367221

RESUMO

Peripheral blood samples of 138 co-habitants from 25 families with recently diagnosed cases of visceral leishmaniasis in the Metropolitan Region of Belo Horizonte, Minas Gerais, Brazil, were analyzed by indirect fluorescent antibody test (IFAT), rK39 and Leishmania chagasi Enzyme Linked Immunosorbent Assay (ELISA), intradermal skin-test and Polymerase Chain Reaction (PCR) over a 12-month period. The cumulative positivity was significantly higher by PCR (29.7%) than by IFAT, rK39 ELISA, L. chagasi ELISA and intradermal skin-test (5.1%, 6.5%, 14.5% and 2.9%, respectively). In addition, the cytokine profile was measured in 16 of the 138 volunteers, of whom eight were asymptomatic carriers and eight were non-infected co-habitants. The innate immunity cells from asymptomatic carriers displayed, upon in vitro antigenic stimulation, a modulated increase in cytokine synthesis that was distinct from that observed in non-infected volunteers. This study suggests that the identification of a large proportion of asymptomatic carriers is facilitated when more than one diagnostic method is applied and that a mixed pattern of immune response is correlated with clinical status of asymptomatic individuals. These observations suggest also that asymptomatic infection by L. chagasi is a frequent event and that control programs could benefit by including this indicator in their interventions.


Assuntos
Anticorpos Antiprotozoários/imunologia , Antígenos de Protozoários/imunologia , Portador Sadio/diagnóstico , Leishmania/imunologia , Leishmaniose Visceral/diagnóstico , Proteínas de Protozoários , Adolescente , Adulto , Idoso , Animais , Anticorpos Antiprotozoários/sangue , Antígenos de Protozoários/sangue , Brasil/epidemiologia , Criança , Pré-Escolar , Ensaio de Imunoadsorção Enzimática/métodos , Técnica Indireta de Fluorescência para Anticorpo/métodos , Humanos , Lactente , Testes Intradérmicos/métodos , Leishmaniose Visceral/sangue , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase , Proteínas de Protozoários/sangue
3.
Diagn Microbiol Infect Dis ; 56(4): 395-400, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16935456

RESUMO

A duplex polymerase chain reaction (PCR) assay was performed using a sense Leishmania genus-specific oligonucleotides to amplify the conserved region of 120 bp of minicircle kDNA and an additional antisense Leishmania donovani oligonucleotide that amplifies a complex-specific fragment of 90 bp. All 12 tested reference isolates of the L. donovani complex yielded a complex-specific amplification product of 90 bp concurrently with a genus-specific 120-bp product. All 17 tested reference isolates pertaining to other complexes presented only the genus-specific 120-bp product. Peripheral blood samples of twenty patients with visceral leishmaniasis positive by the genus-specific PCR presented both fragments with the duplex assay. This duplex PCR can be applied as a 1-step diagnostic tool where discrimination of L. donovani complex species is relevant for clinical and epidemiologic purposes.


Assuntos
Leishmania donovani/isolamento & purificação , Leishmaniose Visceral/diagnóstico , Reação em Cadeia da Polimerase/métodos , Adolescente , Adulto , Animais , Criança , Pré-Escolar , DNA de Cinetoplasto/genética , Feminino , Humanos , Lactente , Leishmania donovani/genética , Masculino , Pessoa de Meia-Idade , Oligonucleotídeos , Oligonucleotídeos Antissenso , Sensibilidade e Especificidade , Tionucleotídeos
4.
Diagn Microbiol Infect Dis ; 51(3): 185-90, 2005 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15766604

RESUMO

The utility of 2 polymerase chain reaction (PCR)-based assays amplifying genus or Viannia subgenus Leishmania minicircle kDNA for the diagnostics of ML was assessed. The Viannia subgenus product was yielded after PCR from isolates of L. (Viannia) braziliensis, L. (Viannia) colombiensis, and L. (Viannia) guyanensis, whereas no product was obtained with the non-Viannia-pertaining species: L. (Leishmania) amazonensis, L. (Leishmania) donovani, and L. (Leishmania) chagasi. With both assays, 11 of 13 (86.4%) patients with confirmed ML could be identified, whereas only 2 (16.7%) of these patients were positive by microscopy. All amplified genus-specific products gave a positive signal by hybridization with a Leishmania (Viannia) subgenus-specific radioactive probe. The Viannia subgenus-specific kDNA PCR represents a sensitive and specific tool for the diagnosis of ML, remarkably improving the sensitivity of parasitological methods and offering an alternative for the radioactive-dependent assays for subgenus characterization.


Assuntos
DNA de Cinetoplasto/genética , Leishmania/genética , Leishmaniose Cutânea/diagnóstico , Reação em Cadeia da Polimerase/métodos , Adulto , Idoso , Idoso de 80 Anos ou mais , Animais , Feminino , Humanos , Leishmania/classificação , Masculino , Pessoa de Meia-Idade , Sensibilidade e Especificidade
5.
Acta Trop ; 92(3): 279-83, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15533299

RESUMO

With the aim of evaluating the utility of the detection of Leishmania kDNA in peripheral blood for the cure assessment of visceral leishmaniasis (VL), a PCR based method was performed in patients with confirmed VL at three follow-up periods after specific chemotherapy with pentavalent antimonial. In 16 out of 17 (94.1%) patients with pre-treatment detectable kDNA that were clinically cured, the PCR turned negative up to 37 days after the initiation of treatment, remaining negative over 90 days after treatment. The clearance of Leishmania kDNA from peripheral blood of patients with VL hints to occur during or shortly after treatment concurring or preceding clinical recovery.


Assuntos
DNA de Cinetoplasto/sangue , Leishmania/efeitos dos fármacos , Leishmaniose Visceral/tratamento farmacológico , Adolescente , Adulto , Animais , Antiprotozoários/uso terapêutico , Criança , Pré-Escolar , Seguimentos , Humanos , Lactente , Leishmania/genética , Leishmania/isolamento & purificação , Leishmaniose Visceral/parasitologia , Meglumina/uso terapêutico , Antimoniato de Meglumina , Pessoa de Meia-Idade , Compostos Organometálicos/uso terapêutico
6.
Diagn Microbiol Infect Dis ; 47(3): 477-85, 2003 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-14596966

RESUMO

Sensitivities and specificities of IgG subclasses-ELISA and IgG-indirect fluorescent antibody test (IFAT) against Leishmania braziliensis (Lb) and L. amazonensis (La) antigens were determined in 17 patients with mucosal (ML) and 19 with muco-cutaneous (MCL) leishmaniasis. Using IFAT-IgG both antigens gave high sensitivities and were statistically similar, being 89.5% with La and 100% with Lb. Using ELISA, the highest sensitivity was achieved with total IgG for ML (94.7% with both antigens) and MCL (100% with both antigens). Cross-reactivity, observed with Chagas disease and malaria sera reduced the specificity of the IgG-based assays, being 50 to 70% with IFAT and 40 to 70% with ELISA. An increase in specificity was obtained with IgG1-ELISA (90% with Lb and 100% with La). Serum levels of anti-Lb-IgG and IgG3 dropped 90 days after treatment. IgG subclasses antibody detection constitute an valuable alternative to increase the efficiency of sorological diagnostics of ML/MCL.


Assuntos
Anticorpos Antiprotozoários/classificação , Leishmania braziliensis/imunologia , Leishmania major/imunologia , Leishmaniose Cutânea/diagnóstico , Leishmaniose Mucocutânea/diagnóstico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Análise de Variância , Animais , Anticorpos Antiprotozoários/análise , Brasil , Estudos de Coortes , Ensaio de Imunoadsorção Enzimática , Feminino , Técnica Indireta de Fluorescência para Anticorpo , Seguimentos , Humanos , Imunoglobulina G/análise , Leishmania braziliensis/isolamento & purificação , Leishmaniose Cutânea/imunologia , Masculino , Pessoa de Meia-Idade , Probabilidade , Estudos de Amostragem , Sensibilidade e Especificidade , Estatísticas não Paramétricas
7.
Rev Soc Bras Med Trop ; 35(3): 259-62, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12045821

RESUMO

A case of HIV/Leishmania co-infection presenting both visceral and cutaneous manifestations is reported. Leishmania infection was confirmed by conventional methods (parasitological approach and serology) and by PCR. Leishmania chagasi isolated from the skin lesion was characterized by enzyme electrophoresis and by restriction fragment length polymorphism of the internal transcribed spacer of the ribosomal gene.


Assuntos
Infecções por HIV/complicações , Leishmania/isolamento & purificação , Leishmaniose/complicações , Adulto , Animais , Evolução Fatal , Infecções por HIV/parasitologia , Humanos , Leishmania/classificação
8.
Rev. Soc. Bras. Med. Trop ; Rev. Soc. Bras. Med. Trop;35(3): 259-262, maio-jun. 2002.
Artigo em Inglês | LILACS | ID: lil-331761

RESUMO

A case of HIV/Leishmania co-infection presenting both visceral and cutaneous manifestations is reported. Leishmania infection was confirmed by conventional methods (parasitological approach and serology) and by PCR. Leishmania chagasi isolated from the skin lesion was characterized by enzyme electrophoresis and by restriction fragment length polymorphism of the internal transcribed spacer of the ribosomal gene.


Assuntos
Adulto , Animais , Humanos , Infecções por HIV/complicações , Leishmania , Leishmaniose , Evolução Fatal , Infecções por HIV/parasitologia , Leishmania
9.
Rev Soc Bras Med Trop ; 35(2): 177-80, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12011927

RESUMO

In August/1999, a group of 14 adults from the staff of a private hospital in Contagem - Minas Gerais State, Brazil, received unintentionally a 25 times concentrated dose of the 17-DD yellow fever vaccine (Bio-Manguinhos), due to a mistake at the reconstitution step. All patients were clinically and laboratorially evaluated at days 5, 13 and 35 post vaccination. Frequency of side effects and clinical observations of this group of individuals were not different from the observed in recipients immunized with normal doses of the vaccine. At the second and third evaluation none of the subjects reported symptoms. None of the patients presented abnormalities at the physical examination at none of the time points and in all cases the blood examination was normal, except for a reduced number of platelets that was detected in one subject at the first and second evaluation and reverted to normal at third evaluation. At the first evaluation point, 8 subjects were serum negative and 6 serum positive for yellow fever at the plaque reduction neutralization test. In 5 subjects the observed titre was 10 times higher as the baseline of 2.36 Log10 mUI/ml. The samples collected at second and third evaluation (13th and 35th days) demonstrated that all subjects responded to the vaccination with the exception of one that did not present a positive result in any of the samples collected. This evaluation confirms the safety of the 17-DD yellow fever vaccine.


Assuntos
Erros de Medicação , Vacina contra Febre Amarela/administração & dosagem , Vacina contra Febre Amarela/efeitos adversos , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
10.
Rev. Soc. Bras. Med. Trop ; Rev. Soc. Bras. Med. Trop;35(2): 177-180, Mar.-Apr. 2002. tab
Artigo em Inglês | LILACS | ID: lil-327482

RESUMO

In August/1999, a group of 14 adults from the staff of a private hospital in Contagem -- Minas Gerais State, Brazil, received unintentionally a 25 times concentrated dose of the 17-DD yellow fever vaccine (Bio-Manguinhos), due to a mistake at the reconstitution step. All patients were clinically and laboratorially evaluated at days 5, 13 and 35 post vaccination. Frequency of side effects and clinical observations of this group of individuals were not different from the observed in recipients immunized with normal doses of the vaccine. At the second and third evaluation none of the subjects reported symptoms. None of the patients presented abnormalities at the physical examination at none of the time points and in all cases the blood examination was normal, except for a reduced number of platelets that was detected in one subject at the first and second evaluation and reverted to normal at third evaluation. At the first evaluation point, 8 subjects were serum negative and 6 serum positive for yellow fever at the plaque reduction neutralization test. In 5 subjects the observed titre was 10 times higher as the baseline of 2.36 Log10 mUI/ml. The samples collected at second and third evaluation (13th and 35th days) demonstrated that all subjects responded to the vaccination with the exception of one that did not present a positive result in any of the samples collected. This evaluation confirms the safety of the 17-DD yellow fever vaccine


Assuntos
Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Erros de Medicação , Vacina contra Febre Amarela/administração & dosagem , Vacina contra Febre Amarela/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA